drugset / Trial / NCT02363127

Subcutaneous Progesterone Versus Vaginal Progesterone for Endometrial Preparation in Fresh Donated Oocytes Recipients

NCT02363127

Phase 4 Completed 120 enrolled Instituto Bernabeu
RandomizedParallel-groupSingle-blindTreatment

Summary

Randomised, prospective, investigator-blinded, controlled, single-centre study to assess the impact on the ongoing pregnancy rate with the use of two progesterones with different administration routes, in recipients of fresh embryos from donor oocytes, undergoing endometrial preparation for fresh embryo transfer.

Timeline

Start
2015-02
Primary completion
2016-10
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 25 mg Subcutaneous
Subject Progesterone Other / unclassified 200 mg Subcutaneous

Indications